Polar Capital Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,000
| Closed | -$2.73M | – | 303 |
|
|
2024
Q4 | $2.73M | Hold |
20,000
| – | – | 0.02% | 261 |
|
|
2024
Q3 | $2.3M | Sell |
20,000
-590,552
| -97% | -$68M | 0.01% | 263 |
|
|
2024
Q2 | $84.1M | Sell |
610,552
-165,004
| -21% | -$22.7M | 0.5% | 57 |
|
|
2024
Q1 | $107M | Sell |
775,556
-60,277
| -7% | -$8.31M | 0.56% | 45 |
|
|
2023
Q4 | $110M | Buy |
835,833
+510,833
| +157% | +$67.3M | 0.67% | 36 |
|
|
2023
Q3 | $36.6M | Sell |
325,000
-50,000
| -13% | -$5.63M | 0.27% | 95 |
|
|
2023
Q2 | $35.4M | Buy |
+375,000
| New | +$35.4M | 0.18% | 109 |
|
|
2023
Q1 | – | Sell |
-173,946
| Closed | -$20.8M | – | 313 |
|
|
2022
Q4 | $20.8M | Hold |
173,946
| – | – | 0.17% | 142 |
|
|
2022
Q3 | $18.5K | Sell |
173,946
-610,341
| -78% | -$64.8K | 0.12% | 149 |
|
|
2022
Q2 | $76.5K | Buy |
784,287
+25,000
| +3% | +$2.44K | 0.45% | 55 |
|
|
2022
Q1 | $71.2K | Buy |
759,287
+725,000
| +2,115% | +$68K | 0.32% | 71 |
|
|
2021
Q4 | $2.92K | Buy |
34,287
+4,472
| +15% | +$381 | 0.01% | 280 |
|
|
2021
Q3 | $2.86K | Sell |
29,815
-134,158
| -82% | -$12.9K | 0.01% | 292 |
|
|
2021
Q2 | $16K | Buy |
163,973
+35,156
| +27% | +$3.42K | 0.07% | 191 |
|
|
2021
Q1 | $12.5M | Buy |
128,817
+6,000
| +5% | +$583K | 0.08% | 191 |
|
|
2020
Q4 | $11.8M | Buy |
+122,817
| New | +$11.8M | 0.07% | 197 |
|